Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

49.30
BATS BZX Real-Time Price
As of 10:08am ET
 +0.22 / +0.45%
Today’s Change
36.76
Today|||52-Week Range
49.59
+28.35%
Year-to-Date

Today’s Trading

Previous close49.08
Today’s open49.21
Day’s range49.14 - 49.45
Volume51,579
Average volume (3 months)7,026,212
Market cap$85.2B
Dividend yield2.15%
Data as of 10:08am ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+12.45%
Earnings growth (next 5 years)+10.95%
Revenue growth (last year)+2.20%
P/E ratio55.5
Price/Sales2.73
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.01+0.02%
AGNAllergan+2.93+1.19%
AZNAstraZeneca+0.09+0.26%
LLYEli Lilly and Co+0.25+0.30%
Data as of 10:08am ET, 06/26/2017

Financials

Next reporting dateJuly 19, 2017
EPS forecast (this quarter)$0.61
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts